VAY736, Placebo Solution for injection or infusion 0 mg/1 mL
CCFZ533H12201BC
Phase 2 small_molecule active
Quick answer
VAY736, Placebo Solution for injection or infusion 0 mg/1 mL for Moderate to severe hidradenitis suppurativa is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Moderate to severe hidradenitis suppurativa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active